Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 5.2B | 5.3B | 5.1B | 5.2B |
Cost of revenue | 4.2B | 4.3B | 4.1B | 4.2B |
Gross profit | 969.5M | 949.0M | 975.5M | 956.6M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 760.9M | 758.2M | 733.6M | 750.3M |
Other operating expenses | — | — | — | — |
Operating income | 208.6M | 190.8M | 241.9M | 206.3M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 11.1M | 10.3M | 12.6M | 12.8M |
Other income expense | -5.0M | -13.3M | -12.5M | -2.6M |
Pretax income | 192.5M | 166.3M | 216.8M | 190.9M |
Tax provision | 42.8M | 43.7M | 61.0M | 45.9M |
Net income | 149.8M | 122.7M | 155.7M | 145.0M |
Basic EPS | 1.1 | 0.9 | 1.2 | 1.1 |
Diluted EPS | 1.1 | 0.9 | 1.2 | 1.0 |
Basic average shares | 131.6M | 131.7M | 132.1M | 132.4M |
Diluted average shares | 132.7M | 133.1M | 133.3M | 133.8M |
EBITDA | 278.3M | 257.7M | 307.6M | 271.4M |
Net income from continuing op. | 149.8M | 122.7M | 155.7M | 145.0M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |